Directional evolution of chlamydia trachomatis towards niche-specific adaptation

Journal of Bacteriology

Volumn 194, Issue 22, 2012, Pages 6143-6153

  Borges, Vítor ^a   Nunes, Alexandra ^a   Ferreira, Rita ^a   Borrego, Maria J ^a   Gomes, João P ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CELL FUNCTION; CELL TYPE; CHLAMYDIA TRACHOMATIS; CODON; EVOLUTION; GENETIC CODE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRACELLULAR BACTERIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEROTYPE;

ADAPTATION, PHYSIOLOGICAL; BIOLOGICAL EVOLUTION; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHROMOSOME MAPPING; CHROMOSOMES, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; GENOME, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MUCOUS MEMBRANE; SELECTION, GENETIC;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 84869132655     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01291-12     Document Type: Article

References (88)

1. Alzhanov DT, Weeks SK, Burnett JR, Rockey DD. 2009. Cytokinesis is blocked in mammalian cells transfected with Chlamydia trachomatis gene CT223. BMC Microbiol. 9:2. doi:10.1186/1471-2180-9-2.
2. Andersson DI, Hughes D. 1996. Muller's ratchet decreases fitness of a DNA-based microbe. Proc. Natl. Acad. Sci. U. S. A. 93:906-907.
3. Andreasen AA, et al. 2008. Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Negl. Trop. Dis. 2:e306. doi:10.1371/ journal.pntd.0000306.
4. Anisimova M, Bielawski J, Dunn K, Yang Z. 2007. Phylogenomic analysis of natural selection pressure in Streptococcus genomes. BMC Evol. Biol. 7:154. doi:10.1186/1471-2148-7-154.
5. Anisimova M, Yang Z. 2007. Multiple hypothesis testing to detect lineages under positive selection that affects only a few sites. Mol. Biol. Evol. 24:1219-1228.
6. Bannantine JP, Griffiths RS, Viratyosin W, Brown WJ, Rockey DD. 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2:35-47.
7. Bannantine JP, Rockey DD, Hackstadt T. 1998. Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol. Microbiol. 28:1017-1026.
8. Belland RJ, et al. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A. 100:8478-8483.
9. Borges V, et al. 2010. Normalization strategies for real-time expression data in Chlamydia trachomatis. J. Microbiol. Methods 82:256-264.
10. Bullock HD, Hower S, Fields KA. 2012. Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins. J. Biol. Chem. 287:28078-28086.
11. Bush RM. 2001. Predicting adaptive evolution. Nat. Rev. Genet. 2:387-392.
12. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. 1999. Predicting the evolution of human influenza A. Science 286:1921-1925.
13. Caldwell HD, et al. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 111:1757-1769.
14. Cambray G, Mazel D. 2008. Synonymous genes explore different evolutionary landscapes. PLoS Genet. 4:e1000256. doi:10.1371/journal.pgen.1000256.
15. Carlson JH, Porcella SF, McClarty G, Caldwell HD. 2005. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect. Immun. 73:6407-6418.
16. Carver T, Thomson N, Bleasby A, Berriman M, Parkhill J. 2009. DNAPlotter: circular and linear interactive genome visualization. Bioinformatics 25:119-120.
17. Chamary JV, Hurst LD. 2005. Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol. 6:R75.
18. Chao L. 1990. Fitness of RNA virus decreased by Muller's ratchet. Nature 348:454-455.
19. Chen L, Perlina A, Lee CJ. 2004. Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase. J. Virol. 78:3722-3732.
20. Clifton DR, et al. 2004. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. U. S. A. 101:10166-10171.
21. Coler RN, et al. 2009. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis. FEMS Immunol. Med. Microbiol. 55:258-270.
22. Crane DD, et al. 2006. Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc. Natl. Acad. Sci. U. S. A. 103:1894-1899.
23. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. doi:10.1371/journal.pone.0011147.
24. Dehoux P, Flores R, Dauga C, Zhong G, Subtil A. 2011. Multi-genome identification and characterization of chlamydia-specific type III secretion substrates: the Inc proteins. BMC Genomics 12:109. doi:10.1186/1471-2164-12-109.
25. Delevoye C, et al. 2008. SNARE protein mimicry by an intracellular bacterium. PLoS Pathog. 4:e1000022. doi:10.1371/journal.ppat.1000022.
26. Egea R, Casillas S, Barbadilla A. 2008. Standard and generalized Mc- Donald-Kreitman test: a website to detect selection by comparing different classes of DNA sites. Nucleic Acids Res. 36(web server issue)W157-62157-62162.
27. Felsenstein J. 1974. The evolutionary advantage of recombination. Genetics 78:737-756.
28. Ferreira R, et al. 2012. Impact of loci nature on estimating recombination and mutation rates in Chlamydia trachomatis. G3 (Bethesda) 2:761-768.
29. Fields KA, Mead DJ, Dooley CA, Hackstadt T. 2003. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during earlycycle development. Mol. Microbiol. 48:671-683.
30. Finco O, et al. 2011. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc. Natl. Acad. Sci. U. S. A. 108:9969-9974.
31. + T cells recognize an inclusion membraneassociated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A. 98:1160-1165.
32. Fraser C, Hanage WP, Spratt BG. 2005. Neutral microepidemic evolution of bacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 102:1968-1973.
33. Gaschen B, et al. 2002. Diversity considerations in HIV-1 vaccine selection. Science 296:2354-2360.
34. Gomes JP, et al. 2006. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect. 8:16-26.
35. Gomes JP, Hsia RC, Mead S, Borrego MJ, Dean D. 2005. Immunoreactivity and differential developmental expression of known and putative Chlamydia trachomatis membrane proteins for biologically variant serovars representing distinct disease groups. Microbes Infect. 7:410-420.
36. Gomes JP, et al. 2006. Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J. Bacteriol. 188:275-286.
37. Gong S, Lei L, Chang X, Belland R, Zhong G. 2011. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology 157:1134-1144.
38. Grimwood J, Stephens RS. 1999. Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae. Microb. Comp. Genomics 4:187-201.
39. Harris SR, et al. 2012. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat. Genet. 44:413-419.
40. Hower S, Wolf K, Fields KA. 2009. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol. Microbiol. 72:1423-1437.
41. Jeffrey BM, et al. 2010. Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect. Immun. 78:2544-2553.
42. Jewett TJ, Dooley CA, Mead DJ, Hackstadt T. 2008. Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases. Biochem. Biophys. Res. Commun. 371:339-344.
43. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T. 2006. Chlamydial TARP is a bacterial nucleator of actin. Proc. Natl. Acad. Sci. U. S. A. 103:15599-15604.
44. Jewett TJ, Miller NJ, Dooley CA, Hackstadt T. 2010. The conserved Tarp actin binding domain is important for chlamydial invasion. PLoS Pathog. 6:e1000997. doi:10.1371/journal.ppat.1000997.
45. Jia TJ, Liu DW, Luo JH, Zhong GM. 2007. Localization of the hypothetical protein CT249 in the Chlamydia trachomatis inclusion membrane. Wei Sheng Wu Xue Bao 47:645-648. (In Chinese.)
46. Jordan IK, et al. 2001. Constant relative rate of protein evolution and detection of functional diversification among bacterial, archaeal, and eukaryotic proteins. Genome Biol. 2:research0053.
47. Jordan IK, Rogozin IB, Wolf YI, Koonin EV. 2002. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. 12:962-968.
48. Jorgensen I, Valdivia RH. 2008. Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion. Infect. Immun. 76:3940-3950.
49. Joseph SJ, Didelot X, Gandhi K, Dean D, Read TD. 2011. Interplay of recombination and selection in the genomes of Chlamydia trachomatis. Biol. Direct 6:28.
50. Kanaya S, Yamada Y, Kudo Y, Ikemura T. 1999. Studies of codon usage and tRNA genes of 18 unicellular organisms and quantification of Bacillus subtilis tRNAs: gene expression level and species-specific diversity of codon usage based on multivariate analysis. Gene 238:143-155.
51. Kari L, et al. 2008. Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J. Infect. Dis. 197:449-456.
52. Kimura M. 1980. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
53. Kimura M. 1983. The neutral theory of molecular evolution. Cambridge University Press, London, England.
54. Le Negrate G, et al. 2008. ChlaDub1 of Chlamydia trachomatis suppresses NF-κB activation and inhibits IκBα ubiquitination and degradation. Cell Microbiol. 10:1879-1892.
55. McDonald JH, Kreitman M. 1991. Adaptive evolution at the adh locus in Drosophila. Nature 351:652-654.
56. Mehlitz A, et al. 2010. Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J. Cell Biol. 190:143-157.
57. Misaghi S, et al. 2006. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61:142-150.
58. Mital J, Miller NJ, Fischer ER, Hackstadt T. 2010. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell Microbiol. 12:1235-1249.
59. Mitchell-Olds T, Willis JH, Goldstein DB. 2007. Which evolutionary processes influence natural genetic variation for phenotypic traits? Nat. Rev. Gen. 8:845-856.
60. Muller HJ. 1964. The relation of recombination to mutational advance. Mutat. Res. 106:2-9.
61. Nei M, Kumar S. 2000. Molecular evolution and phylogenetics. Oxford University Press, New York, NY.
62. Nielsen R. 2001. Statistical tests of selective neutrality in the age of genomics. Heredity 86:641-647.
63. Nunes A, et al. 2007. Comparative expression profiling of the Chlamydia trachomatis pmp gene family for clinical and reference strains. PLoS One 2:e878. doi:10.1371/journal.pone.0000878.
64. Nunes A, Nogueira PJ, Borrego MJ, Gomes JP. 2010. Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B- and T-cell epitopes: worldwide survey. PLoS One 5:e13171. doi:10.1371/journal.pone.0013171.
65. Read TD, et al. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
66. Rockey DD, Scidmore MA, Bannantine JP, Brown WJ. 2002. Proteins in the chlamydial inclusion membrane. Microbes Infect. 4:333-340.
67. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
68. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T. 1999. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33:753-765.
69. Sharma J, et al. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.
70. Sharp PM, Tuohy TM, Mosurski KR. 1986. Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes. Nucleic Acids Res. 14:5125-5143.
71. Sisko JL, Spaeth K, Kumar Y, Valdivia RH. 2006. Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Mol. Microbiol. 60:51-66.
72. Starnbach MN, et al. 2003. An inclusion membrane protein from Chlamydia trachomatis enters theMHCclass I pathway and stimulates a CD8+ T cell response. J. Immunol. 171:4742-4749.
73. Stephens RS. 2002. Chlamydiae and evolution: a billion years and counting, p 3-12. In Schachter J, et al. (ed), Chlamydial infections: proceedings of the 10th International Symposium on Human Chlamydial Infections. International Chlamydia Symposium, San Francisco, CA.
74. Stephens RS, et al. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759.
75. Subtil A, et al. 2005. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol. Microbiol. 56:1636-1647.
76. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximumparsimony methods. Mol. Biol. Evol. 28:2731-2739.
77. Tan C, et al. 2010. Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis. Cell Microbiol. 12:174-187.
78. Tan C, et al. 2009. Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect. Immun. 77:3218-3226.
79. Thomson NR, et al. 2008. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res. 18:161-171.
80. Vos M. 2009. Why do bacteria engage in homologous recombination? Trends Microbiol. 17:226-232.
81. Wang J, et al. 2009. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine 27:2967-2980.
82. Yang Z. 1998. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol. Biol. Evol. 15:568-573.
83. Yang Z. 2007. PAML 4: a program package for phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24:1586-1591.
84. Yang Z, dos Reis M. 2011. Statistical properties of the branch-site test of positive selection. Mol. Biol. Evol. 28:1217-1228.
85. Yang Z, Nielsen R. 2002. Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol. Biol. Evol. 19:908-917.
86. Yang Z, Nielsen R. 2000. Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol. Biol. Evol. 17:32-43.
87. Yang Z, Wong WS, Nielsen R. 2005. Bayes empirical Bayes inference of amino acid sites under positive selection. Mol. Biol. Evol. 22:1107-1118.
88. Zhang J, Nielsen R, Yang Z. 2005. Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. Mol. Biol. Evol. 22:2472-2479.